Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Archer completes potassium sensing alpha prototype

Quantum technology company Archer Materials Limited has developed an early Biochip prototype...

Content from other channels on our network

Electric actuation: a gamechanger for upstream processes

Government seeks input on wind and transmission infrastructure

Additive manufacturing unlocks power for space and defence missions

Video-based water detection reduces contamination in gas pipeline

Government finalises Net Zero Fund design

Abattoir safety program in WA raises more awareness

Electric trucks hit the road to deliver beer in Perth

Closing the loop with food packaging made from fish skin waste

Fonterra announces Mainland Group leadership change

Barry Callebaut opens chocolate innovation centre in Singapore

Liquid metal to 'harvest' clean hydrogen from water

Epson makes progress with sustainability plans and initiatives in Australia and New Zealand

Sustainable wastewater treatment achieved for urban areas

'Brownfielding' increases to meet metal demand

NSW to exceed energy storage targets